Cargando…
Recurrent cystoid macular edema following Boston keratoprosthesis type-II implantation: A treatment option
A 68-year-old woman with end-stage Stevens–Johnson syndrome developed cystoid macular edema (CME) 3 months following Boston keratoprosthesis type II (KPro-II) implantation and treated with single-dose injection of triamcinolone acetonide (TA) in the inferior peribulbar region. After 14 days, CME res...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640875/ https://www.ncbi.nlm.nih.gov/pubmed/32709826 http://dx.doi.org/10.4103/ijo.IJO_2322_19 |
_version_ | 1783605836691537920 |
---|---|
author | Basak, Samar K Basak, Soham |
author_facet | Basak, Samar K Basak, Soham |
author_sort | Basak, Samar K |
collection | PubMed |
description | A 68-year-old woman with end-stage Stevens–Johnson syndrome developed cystoid macular edema (CME) 3 months following Boston keratoprosthesis type II (KPro-II) implantation and treated with single-dose injection of triamcinolone acetonide (TA) in the inferior peribulbar region. After 14 days, CME resolved completely, and she regained 20/30 vision. Seven months later, she developed recurrent CME. She was again treated with a similar peribulbar injection of TA. CME was resolved completely after 2 weeks with full visual and anatomical recovery. Here, we present a case of recurrent CME following KPro-II implantation responsive to peribulbar injection of TA, which may be the only effective treatment option. |
format | Online Article Text |
id | pubmed-7640875 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-76408752020-11-05 Recurrent cystoid macular edema following Boston keratoprosthesis type-II implantation: A treatment option Basak, Samar K Basak, Soham Indian J Ophthalmol Case Reports A 68-year-old woman with end-stage Stevens–Johnson syndrome developed cystoid macular edema (CME) 3 months following Boston keratoprosthesis type II (KPro-II) implantation and treated with single-dose injection of triamcinolone acetonide (TA) in the inferior peribulbar region. After 14 days, CME resolved completely, and she regained 20/30 vision. Seven months later, she developed recurrent CME. She was again treated with a similar peribulbar injection of TA. CME was resolved completely after 2 weeks with full visual and anatomical recovery. Here, we present a case of recurrent CME following KPro-II implantation responsive to peribulbar injection of TA, which may be the only effective treatment option. Wolters Kluwer - Medknow 2020-08 2020-07-24 /pmc/articles/PMC7640875/ /pubmed/32709826 http://dx.doi.org/10.4103/ijo.IJO_2322_19 Text en Copyright: © 2020 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Reports Basak, Samar K Basak, Soham Recurrent cystoid macular edema following Boston keratoprosthesis type-II implantation: A treatment option |
title | Recurrent cystoid macular edema following Boston keratoprosthesis type-II implantation: A treatment option |
title_full | Recurrent cystoid macular edema following Boston keratoprosthesis type-II implantation: A treatment option |
title_fullStr | Recurrent cystoid macular edema following Boston keratoprosthesis type-II implantation: A treatment option |
title_full_unstemmed | Recurrent cystoid macular edema following Boston keratoprosthesis type-II implantation: A treatment option |
title_short | Recurrent cystoid macular edema following Boston keratoprosthesis type-II implantation: A treatment option |
title_sort | recurrent cystoid macular edema following boston keratoprosthesis type-ii implantation: a treatment option |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640875/ https://www.ncbi.nlm.nih.gov/pubmed/32709826 http://dx.doi.org/10.4103/ijo.IJO_2322_19 |
work_keys_str_mv | AT basaksamark recurrentcystoidmacularedemafollowingbostonkeratoprosthesistypeiiimplantationatreatmentoption AT basaksoham recurrentcystoidmacularedemafollowingbostonkeratoprosthesistypeiiimplantationatreatmentoption |